Invesco Dynamic Pharmaceuticals ETF company info

What does Invesco Dynamic Pharmaceuticals ETF do?
Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) focuses on investing in a diverse range of companies within the pharmaceutical sector, seeking to track the performance of the Dynamic Pharmaceutical Intellidex Index. This ETF aims to provide investors with exposure to the pharmaceutical industry, including companies involved in the research, development, manufacture, and distribution of various pharmaceuticals and related products. The investment strategy emphasizes identifying companies with the potential for growth and innovation in the development of new drugs and medical treatments. By investing in Invesco Dynamic Pharmaceuticals ETF, investors gain an opportunity to participate in the potential growth of the pharmaceutical sector, aiming to achieve long-term capital appreciation. The ETF is designed to cater to investors looking for sector-specific exposure within their investment portfolios, aligning with the objectives of capital growth through strategic investments in the dynamic and evolving pharmaceutical industry.
Invesco Dynamic Pharmaceuticals ETF company media
Company Snapshot

Is Invesco Dynamic Pharmaceuticals ETF a public or private company?

key
Ownership
Public

How many people does Invesco Dynamic Pharmaceuticals ETF employ?

people
Employees
5,025

What sector is Invesco Dynamic Pharmaceuticals ETF in?

pie chart
Sector
ETF

Where is the head office for Invesco Dynamic Pharmaceuticals ETF?

location pin
Head Office
Atlanta, United States

What year was Invesco Dynamic Pharmaceuticals ETF founded?

founded flag
Year Founded
2005
What does Invesco Dynamic Pharmaceuticals ETF specialise in?
/Pharmaceutical Investments /Sector ETF /Diversified Portfolio /Equity Funds /Asset Management /Investment Services

What are the products and/or services of Invesco Dynamic Pharmaceuticals ETF?

Overview of Invesco Dynamic Pharmaceuticals ETF offerings
Investment in Pharmaceutical Stocks: Focuses on equity investments in U.S. pharmaceutical companies, aiming for capital growth.
Sector Rotation Strategy: Adapts investment allocations based on market trends within the pharmaceutical sector.
Dividend Investment: Seeks dividends from high-performing pharmaceutical companies, aiming to provide income to investors.
Risk Management: Utilizes various strategies to mitigate investment risk, including diversification among pharmaceutical entities.
Innovation Focus: Prioritizes companies involved in innovative drug development and technological advancements in healthcare.
Global Expansion: Looks at opportunities in global markets, especially in emerging economies with growing pharmaceutical sectors.